Profilo
Christian M.
Pangratz is currently Chief Executive Officer at Atriva Therapeutics GmbH since 2023 and Chief Executive Officer at Urteste SA starting in 2026.
Former positions include Chief Executive Officer & Director at Orikine Bio SL, Executive Director-Business Development at Nektar Therapeutics, Managing Director at sterna biologicals GmbH, Executive Vice President-Business Development at SkyePharma Plc, Principal at Bayer AG, Chief Business Officer at Vectura GmbH from 2013 to 2014, Principal at Pfizer GmbH, and Principal at Vienna GmbH.
Education includes undergraduate and graduate degrees from Webster University.
Posizioni attive di Christian Pangratz
| Società | Posizione | Inizio |
|---|---|---|
| URTESTE S.A. | Amministratore Delegato | 01/09/2026 |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Amministratore Delegato | 15/01/2023 |
Precedenti posizioni note di Christian Pangratz
| Società | Posizione | Fine |
|---|---|---|
Orikine Bio SL
Orikine Bio SL BiotechnologyHealth Technology Operates as biotech company the develops cytokine based therapies to treat autoimmune, inflammatory and other immune mediated diseases | Amministratore Delegato | 08/09/2026 |
Vectura GmbH
Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Corporate Officer/Principal | 01/09/2014 |
sterna biologicals GmbH
sterna biologicals GmbH Pharmaceuticals: MajorHealth Technology Produces pharmaceuticals for asthma and chronic diseases | Amministratore Delegato | - |
| SKYEPHARMA PLC | Corporate Officer/Principal | - |
Vienna GmbH
Vienna GmbH Financial ConglomeratesFinance Operates as an investment firm | Corporate Officer/Principal | - |
Formazione di Christian Pangratz
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Nektar Therapeutics
Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
SkyePharma Plc
SkyePharma Plc Pharmaceuticals: OtherHealth Technology Manufactures and develops oral and inhalation pharmaceutical products | Health Technology |
Bayer AG
Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Webster University
Webster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vectura GmbH
Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Commercial Services |
Pfizer GmbH | |
Vienna GmbH
Vienna GmbH Financial ConglomeratesFinance Operates as an investment firm | Finance |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Health Technology |
sterna biologicals GmbH
sterna biologicals GmbH Pharmaceuticals: MajorHealth Technology Produces pharmaceuticals for asthma and chronic diseases | Health Technology |
Urteste SA
Urteste SA Medical SpecialtiesHealth Technology Develops diagnostic tests for most common cancers | Health Technology |
Orikine Bio SL
Orikine Bio SL BiotechnologyHealth Technology Operates as biotech company the develops cytokine based therapies to treat autoimmune, inflammatory and other immune mediated diseases | Health Technology |
















